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A B ST R AC T  
 
Proximal Sars-Cov-2 pandemic had radically changed the way surgeons work in many departments, 
forcing to reserve surgical treatment only for emergency and oncologic cases. We report a case of a 
ten months-old girl with right-sided Wilms tumor and a previous diagnosis of Sars-Cov-2 infection, 
who underwent open right nephrectomy. Surgery was planned after negativization of five 
nasopharyngeal tests, despite the simultaneous positivity of two rectal swabs. The procedure was 
performed safely with appropriate personal protective equipment (PPE). To better investigate viral 
excretion, the anesthetist repeated nasopharyngeal swab under general anesthesia, which resulted 
positive. At the same time, two peritoneal swabs were collected and showed the absence of the virus 
in the peritoneal fluid. This case highlights the importance of combining swabs from various sources 
to increase sensibility of the test. The value of nasopharyngeal swab under general anesthesia should 
be reinforced as it can result positive even after many negative tests. Very little is known about 
transmission of the virus through the peritoneum as both presence and absence of Sars-Cov-2 have 
been reported in the peritoneal fluid. Upcoming literature will clarify which particular conditions 
determine viral penetration in this anatomical district.          
Key Words: COVID-19, peritoneal swab, Wilms tumor, nephrectomy, pediatric surgery, pediatric 
urology.                                                                                             
          © 2020 pediatricurologycasereports.com                                 
        Dr. Alberto Mantovani, FEAPU,  
Department of Pediatric Urology, Meyer Children’s 
Hospital, Viale Pieraccini 24, Florence, Italy.   
E-mail: alberto.mantovani@meyer.it  
Received: 2020-05-27 / Accepted: 2020-06-08 
Publication Date: 2020-07-01 
 
Introduction 
During COVID-19 pandemic, pediatric 
surgery departments of most countries 
experienced a dramatic reduction in the 
elective surgical activity, continuing to offer 
surgical treatment only for emergency and 
oncological cases [1-4]. Any patient currently 
approaching to surgery needs the diagnosis of 
COVID-19 positive or negative. The test has to 
be as quick and reliable as possible in order to 
take appropriate personal protective 
equipment (PPE) and pathway [5]. 
We present a case of Wilms tumor with 
different combination of nasopharyngeal, fecal 
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and peritoneal swabs results during the 
hospitalization and give a prospective thought 
for the management of surgical patients during 
the easing of the lockdowns and beyond. 
 
Case report 
A ten months-old girl was admitted the 1st of 
March 2020 to the emergency department with 
hyperpyrexia, signs of urinary tract 
infection (UTI) and a palpable right abdominal 
mass. US scan confirmed the presence of a 
right renal mass of 10 cm and urine culture 
showed E. coli infection. Intravenous 
antibiotic therapy was initiated. Magnetic 
resonance imaging (MRI) (Fig. 1A, B) and 
computed tomography (CT) scans confirmed 
the suspect of right localized Wilms tumor and 
she was commenced on chemotherapy 
following the Umbrella SIOP-RTSG 2016 
Wilms tumor protocol [1]. The first two cycles 
were uneventful. 
Two days after the third cycle of chemotherapy 
she came to the local emergency department 
with hyperpyrexia: urinary stick and routine 
blood tests were negative but nasopharyngeal 
swab for Sars-Cov-2 turned positive. Chest-CT 
was subsequently performed and was negative. 
She was then admitted through a Covid-19 
positive patient pathway and isolated. The 
fourth cycle of chemotherapy was postponed. 
During the hospitalization she became afebrile, 
with no pulmonary involvement. She was 
discharged four days later with two negative 
nasopharyngeal swabs. Two weeks later 
hyperpyrexia reoccurred without any other 
sign or symptoms. Nasopharyngeal swabs 
were repeated on the patient and patient’s 
mum: they resulted negative and positive 
respectively. Urine culture showed multi-drug 
resistant Klebsiella Pneumoniae. Chest X-ray 
was negative. Subsequently the baby was 
hospitalized again following COVID-19 
positive patient pathway. UTI was treated with 
Meropenem according to antibiogram.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1A, B. Right Wilms tumor at pre-op MRI 
after 4 cycles of chemotherapy. 
 
During the hospitalization nasopharyngeal 
swabs for Sars-Cov-2 were performed every 
48h for 12 days, and they always resulted 
negative. The virus was then searched on 
feces: real time polymerase chain reaction 
(PCR) performed on rectal swabs resulted 
positive in two different specimens, despite the 
negativity of simultaneous nasopharyngeal 
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samples. Patient’s clinical conditions 
progressively improved and she received the 
4thcycle of chemotherapy. Checked-MRI 
showed no significant improvement of mass 
volume. In agreement with anesthesiologists, 
considering multiple negative pharyngeal 
swabs and adequate time from last 
chemotherapy, open radical right nephrectomy 
was considered safe and was performed.   
To investigate the pattern of viral excretion the 
anesthetist repeated nasopharyngeal swab 
under general anesthesia (GA), which resulted 
positive for Sars-Cov-2.  
Moreover, two swabs of peritoneal fluid taken 
by the surgeon showed no virus. No intra-
operative complications were recorded and the 
recovery was uneventful. 
 
Discussion 
Knowledge about COVID-19 is rapidly 
emerging through scientific publications in 
different fields of medicine. Recent guidelines 
focused on the revision of the indication for 
surgery with the aim to minimize theatre 
utilization for non-urgent conditions [2]. 
Parallel to that, particular attention has been 
paid on the safety of those procedures 
proposed during pandemic. First of all, all 
patients undergoing surgery should be tested 
for COVID-19. The results will influence the 
patient’s pathways and staff behaviors within 
the hospital, including theatre [3]. The test 
currently used worldwide is the 
nasopharyngeal swab: viral nucleic acid (NAT: 
nucleic acid test) is searched using real-time 
reverse transcriptase-polymerase chain 
reaction (RT-PCR). This can confirm the virus 
infection within 2 hours [4]. It is also known 
that nasopharyngeal swabs are more sensitive 
when symptoms first emerge and swabs from 
both sides are often combined to increase 
sensitivity [6]. Previous authors suggested a 
sensitivity as low as 32 to 63% in children [7]. 
Reasons for the low efficiency may include 
immature development of nucleic acid 
detection technology, variation in detection 
rate from different manufacturers, low patient 
viral load or improper clinical sampling [8]. 
The case presented shows how the 
nasopharyngeal test can be misleading, even in 
the unusual scenario of multiple negative 
results. In fact, only the swab taken under GA 
was positive for Sars-Cov-2 in our case. As a 
consequence, the power of the test must 
depend in part on the experience of who 
performs it, being this rule new for many 
healthcare workers who often learned the 
procedure without appropriate training. 
Moreover, an impact on the final results must 
be also given by the patient compliance during 
the swab, which is minimal in case of young 
children. For those reasons we strongly 
recommend to perform always another 
nasopharyngeal swab under GA at the 
beginning of the procedure, which can change 
the pathway of the patient in case of an 
unrecognized positivity at the time of 
admission. Fortunately, our case had positive 
rectal swab, which determined a safe COVID-
19 pathway. Rectal swabs have already shown 
to persist positive even after the negativization 
of nasopharyngeal test, as reported by Xu et al 
[9]. Moreover, the same author described two 
patients discharged after two consecutive 
negative rectal swabs, who turned positive at 
the same test 7 and 13 days after discharge, 
according with the theory of different phases 
of viral excretion [9]. Those findings suggest 
that rectal swab-testing may be more useful 
than nasopharyngeal ones in judging the state 
of the infection and determining the timing for 
termination of quarantine. Xiao et al recently 
gave evidence of replication-competent virus 
in feces, confirming the potential for fecal–oral 
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transmission [10]. Doing many swabs in 
different locations and at different times during 
the patient hospitalization may lead to 
confusion and unnecessary delay in 
procedures, as well as risks for safety of 
medical staff or, on the other hand, 
inappropriate use of PPE. Development of an 
accurate quick-test for Sars-Cov-2 is essential 
and many laboratories are working on this 
topic [11]. Even if Sars-Cov-2 has been found 
in many specimens from different anatomical 
sites, data are currently lacking regarding the 
incidence of Sars-Cov-2 in the abdominal 
cavity, in patients with positive 
nasopharyngeal or rectal swab [6]. This has led 
to suggest open approach instead of 
laparoscopy, or the insufflation or the 
disinflation of the abdomen in a closed circuit, 
in those cases where laparoscopy was 
indicated and before converting from 
laparoscopy to open surgery [12]. In our case, 
no viral nucleic acid, tested using RT-PCR, 
was found on two different peritoneal swabs 
taken at the time of surgery, while pharyngeal 
swab taken at the same time resulted positive. 
However, Coccolini et al have recently 
identified virus from peritoneal swab in a 78 
years old man with Sars-Cov-2 bilateral 
pneumonia, who underwent surgery for 
intestinal mechanical obstruction due to small 
bowel volvulus [13]. We recommend taking 
peritoneal swabs during any abdominal 
surgery in order to avoid missing positive 
patients who might contribute to spread the 
infection if not recognized and adequately 
isolated. 
Conclusions 
COVID19 will probably influence our practice 
for the next year at least. It is important to test 
the patients appropriately and possibly from 
more than one source. This will help to 
understand viral behavior among different 
cohorts of subjects and act consequently. Our 
case report shows the possible value of 
nasopharyngeal test under GA independently 
from the result of previous swabs. Moreover, 
the combination of swabs from various sources 
should improve the sensibility to identify 
patients who are carrying the virus.  
Hopefully, more data from peritoneal swabs 
will be soon available for adult and children, 
helping the decision-making process before 
undertaking surgery.   
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